Navigation Links
Recent Studies Suggest Popular 'Diet Pill' Relacore Reduces Acne Breakouts
Date:2/15/2008

NEW YORK, Feb. 15 /PRNewswire/ -- As crazy as it sounds, recent studies conducted at Stanford and Wake Forest Schools of Medicine suggest there's a connection between stubborn stress-related belly bulge, unsightly acne flare- ups and the so-called "Belly Fat" pill, Relacore(R) (from the Carter-Reed Company) ... and that link is stress. By now we've all heard that stress increases cortisol (the stress hormone) and cortisol increases "belly fat." Well, now it seems that stress also increases both the frequency and the severity of acne breakouts.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080215/LAF031 )

While this may be terrible news for millions of us who seem to be stressed-out even on the best of days, it turns out to be great news for the Carter-Reed Company. You see, Carter-Reed makes Relacore, the anti-stress feel-good pill that has become America's #1 selling "Belly Fat" pill because of the connection between stress and abdominal fat. In fact, Carter-Reed is seeing a huge spike in sales as more people understand that controlling stress will not only help reduce "belly bulge" but can also help lessen the frequency and severity of acne breakouts.

"Relacore is what's known as an adjunct, an 'add-on' product," says Gina Daines, Carter-Reed's Director of Marketing. "One of the reasons Relacore has been so successful is because people buy it along with other diet pills or to use in conjunction with any sensible diet and exercise plan. Why? Because most people find that dieting itself is stressful; that's why even when we lose weight we seem to retain that extra roll around the middle. Now when it comes to acne, we're seeing the same phenomenon: those who buy popular anti-acne treatments, like Proactive(R), are picking up a bottle of Relacore to expand and complete their anti-acne regimen, using Relacore to help prevent the stress-related increase, duration, frequency and severity of acne flare-ups."

The Science

In a recent study, the largest ever conducted on the relationship between stress and acne flare-ups ("Study of Psychological Stress, Sebum Production and Acne Vulgaris in Adolescents," Acta Dermato-Venereologica (2007), Department of Dermatology, Wake Forest School of Medicine), the acne-stress connection was unequivocally confirmed. Lead author and dermatologist Gil Yosipovitch, M.D. said in an interview published in Medical News Today, "Acne significantly affects physical and psychosocial well-being, so it is important to understand the interplay between the factors that exacerbate acne. Our study suggests a significant association between stress and severity of acne."

This research also confirmed the results of a landmark 2003 dermatological study which first revealed that stress significantly increases the severity of acne outbreaks: "Acne severity correlate(s) highly with increasing stress, suggesting that emotional stress from external sources may have a significant influence on acne." ("The Response of Skin Disease to Stress: Changes in the Severity of Acne Vulgaris as Affected by Examination Stress," Archives of Dermatology (2003) Department of Dermatology, Stanford School of Medicine)

So if you're looking for America's newest and most surprising weapon in the fight against stress-related acne flare-ups, don't look in the skin care section of your local pharmacy. You'll have to go to the diet section to find Relacore ... America's #1 selling "Belly Fat" pill and a "must have" addition in your quest for clear, flawless skin.


'/>"/>
SOURCE Carter-Reed Company for Relacore
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
2. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
3. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
4. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
5. Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology
6. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
7. N30 Pharma Announces Successful Initiation of Human Studies With N30-201
8. Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
9. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
10. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
11. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ST. LOUIS , Feb. 17, 2017   ... hospitals, has announced a new partnership with Engage ... the United States . FormFast will serve ... part of Engage,s implementations with MEDITECH .  ... that provides essential functionality to complement and enhance the ...
(Date:2/16/2017)... Pa. , Feb. 16, 2017 Absorption ... biologics, and medical devices, is pleased to announce that ... has been selected as a winner of the 2017 ... SmartCEO Magazine and recognizes driven executives for their ... work ethic. The awards ceremony and celebration is on ...
(Date:2/16/2017)... , Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company, today announced that executive management will participate ... be held February 22-23, 2017. Adrian Adams , ... Company at 1:35 p.m. local time on Wednesday, February ... archive for the event may be accessed from the ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... Access ... & Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) ... widely used electronic patient signatures solution in healthcare . , Since it ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended CHI's 8th ... of clinical trial planning and management. Pharmica discussed the importance of effective project ... attendees stopping by Pharmica’s booth were able to demo its cloud-based Resource ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... Like most ... reduce readmissions. Driven in large part by the Hospital Readmission Reduction Program (HRRP), the ... a key focus area for hospitals across the nation. While many providers are struggling ...
(Date:2/17/2017)... ... February 17, 2017 , ... Dillon Ruxton Insurance, a Florida-based ... owners in the greater Fort Lauderdale metropolitan region, is embarking on a cooperative ... 30 years, LifeNet 4 Families has provided a broad range of food provision ...
(Date:2/16/2017)... , ... February 17, 2017 , ... Teaching nursing care ... program, now in development. ACE.P (pediatrics) is being created with the support of the ... of Vulnerable Populations , ACE.P will address what has been identified as a critical ...
Breaking Medicine News(10 mins):